Workflow
Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor
IINNInspira Technologies Oxy B.H.N. .(IINN) Prnewswire·2025-02-05 13:30

Core Viewpoint - Inspira Technologies has developed an innovative AI-powered blood sensor technology, HYLA, which enables continuous monitoring of tissue oxygenation and early detection of hypoxia, with preliminary clinical results expected soon [1][3]. Group 1: Technology and Innovation - The integration of a next-generation oxygenation indicator into the HYLA blood sensor represents a significant enhancement in critical care monitoring, allowing for real-time and continuous monitoring of oxygenation therapy [2][4]. - The HYLA technology positions itself as a potential game-changer in the 2.5billionpoint−of−caretestingandarterialbloodgasanalyzermarket[2].−Thenon−invasivetechnologyutilizesadvancedopticalsensorsandmachine−learningalgorithmsforcontinuousmonitoringofbloodparametersandoxygenlevels[3].Group2:ClinicalValidationandRegulatoryPath−ClinicalvalidationoftheenhancedHYLAbloodsensoriscurrentlyunderwayatShebaMedicalCenter,whichisrecognizedasoneoftheworld′stopsmarthospitals[3].−ThecompanyanticipatessubmittingforFDAregulatoryclearanceinthesecondhalfof2025[3].Group3:MarketPotentialandApplications−InspiraTechnologieshasdevelopedtheAugmentedRespirationTechnology(INSPIRAART),whichaimstorevolutionizethe2.5 billion point-of-care testing and arterial blood gas analyzer market [2]. - The non-invasive technology utilizes advanced optical sensors and machine-learning algorithms for continuous monitoring of blood parameters and oxygen levels [3]. Group 2: Clinical Validation and Regulatory Path - Clinical validation of the enhanced HYLA blood sensor is currently underway at Sheba Medical Center, which is recognized as one of the world's top smart hospitals [3]. - The company anticipates submitting for FDA regulatory clearance in the second half of 2025 [3]. Group 3: Market Potential and Applications - Inspira Technologies has developed the Augmented Respiration Technology (INSPIRA ART), which aims to revolutionize the 19 billion mechanical ventilation market by stabilizing oxygen saturation levels without the use of a ventilator [5]. - The INSPIRA ART, combined with the HYLA blood sensor, aims to provide a comprehensive approach to patient care by enabling continuous, non-invasive monitoring while patients remain conscious during treatment [4][5].